$CGIX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Vyant Bio, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Vyant Bio, Inc.. Get notifications about new insider transactions in Vyant Bio, Inc. for free.

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 01 2021	CGIX	Vyant Bio, Inc.	FLETCHER R JOHN	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	FLETCHER R JOHN	Director	Option Exercise	J	1.56	10,265	16,013	10,265
Apr 01 2021	CGIX	Vyant Bio, Inc.	FLETCHER R JOHN	Director	Grant	A	0.00	8,676	0	8,676	0 to 8.7 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Option Exercise	J	0.96	15,547	14,925	15,547
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Option Exercise	J	1.56	1,619	2,526	1,619
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Option Exercise	J	1.56	5,068	7,906	5,068
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Buy	J	0.00	93,929	0	93,929	0 to 93.9 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	FLETCHER R JOHN	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	FLETCHER R JOHN	Director	Option Exercise	J	1.56	10,265	16,013	10,265
Apr 01 2021	CGIX	Vyant Bio, Inc.	Horobin Joanna	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	FLETCHER R JOHN	Director	Grant	A	0.00	8,676	0	8,676	0 to 8.7 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	Horobin Joanna	Director	Option Exercise	J	1.56	5,068	7,906	5,068
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Option Exercise	J	0.96	15,547	14,925	15,547
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Option Exercise	J	1.56	1,619	2,526	1,619
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Option Exercise	J	1.56	5,068	7,906	5,068
Apr 01 2021	CGIX	Vyant Bio, Inc.	Boehm Marcus	Director	Buy	J	0.00	93,929	0	93,929	0 to 93.9 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	McLeod Howard	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	Yeh Yung-Ping	Chief Innovation Of ...	Option Exercise	A	4.61	150,000	691,500	150,000
Apr 01 2021	CGIX	Vyant Bio, Inc.	Yeh Yung-Ping	Chief Innovation Of ...	Option Exercise	J	1.56	51,825	80,847	51,825
Apr 01 2021	CGIX	Vyant Bio, Inc.	Yeh Yung-Ping	Chief Innovation Of ...	Buy	J	0.00	1,328,602	0	1,328,602	0 to 1.3 M
Apr 01 2021	CGIX	Vyant Bio, Inc.	Hansen Paul R.	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	Hansen Paul R.	Director	Buy	J	0.00	65,000	0	65,000	0 to 65 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	Hansen Paul R.	Director	Buy	J	0.00	592,548	0	592,548	0 to 592.5 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	Harris Geoffrey E.	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	Horobin Joanna	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	Horobin Joanna	Director	Option Exercise	J	1.56	5,068	7,906	5,068
Apr 01 2021	CGIX	Vyant Bio, Inc.	Brandt Ralf	President, Discover ...	Option Exercise	A	4.61	100,000	461,000	100,000
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Option Exercise	A	4.61	100,000	461,000	100,000
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Option Exercise	J	1.56	38,868	60,634	38,868
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Option Exercise	J	1.56	172,944	269,793	172,944
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Buy	J	0.00	26,866	0	26,866	0 to 26.9 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Buy	J	0.00	29,336	0	29,336	0 to 29.3 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	McLeod Howard	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	Yeh Yung-Ping	Chief Innovation Of ...	Option Exercise	A	4.61	150,000	691,500	150,000
Apr 01 2021	CGIX	Vyant Bio, Inc.	ROBERTS JOHN A	Chief Executive Off ...	Option Exercise	A	4.61	250,000	1,152,500	250,000
Apr 01 2021	CGIX	Vyant Bio, Inc.	Yeh Yung-Ping	Chief Innovation Of ...	Option Exercise	J	1.56	51,825	80,847	51,825
Apr 01 2021	CGIX	Vyant Bio, Inc.	Yeh Yung-Ping	Chief Innovation Of ...	Buy	J	0.00	1,328,602	0	1,328,602	0 to 1.3 M
Apr 01 2021	CGIX	Vyant Bio, Inc.	Hansen Paul R.	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	Hansen Paul R.	Director	Buy	J	0.00	65,000	0	65,000	0 to 65 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	Hansen Paul R.	Director	Buy	J	0.00	592,548	0	592,548	0 to 592.5 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	Harris Geoffrey E.	Director	Option Exercise	A	4.61	13,015	59,999	13,015
Apr 01 2021	CGIX	Vyant Bio, Inc.	Brandt Ralf	President, Discover ...	Option Exercise	A	4.61	100,000	461,000	100,000
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Option Exercise	A	4.61	100,000	461,000	100,000
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Option Exercise	J	1.56	38,868	60,634	38,868
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Option Exercise	J	1.56	172,944	269,793	172,944
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Buy	J	0.00	26,866	0	26,866	0 to 26.9 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	LaFrence Andrew D.C.	Chief Financial Off ...	Buy	J	0.00	29,336	0	29,336	0 to 29.3 K
Apr 01 2021	CGIX	Vyant Bio, Inc.	ROBERTS JOHN A	Chief Executive Off ...	Option Exercise	A	4.61	250,000	1,152,500	250,000
Apr 28 2020	CGIX	CANCER GENETICS, I ...	Brandt Ralf	President, Discover ...	Option Exercise	A	5.53	10,000	55,300	10,000
Apr 28 2020	CGIX	CANCER GENETICS, I ...	Miles Michael Glenn	Chief Financial Off ...	Option Exercise	A	5.53	10,000	55,300	10,000
Aug 21 2019	CGIX	CANCER GENETICS, I ...	PRENDERGAST FRANKLYN G	Director	Option Exercise	A	0.15	100,000	15,000	100,000
Aug 19 2019	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Option Exercise	A	0.15	100,000	15,000	100,000
Aug 19 2019	CGIX	CANCER GENETICS, I ...	Chaganti Raju S.K.	Director	Option Exercise	A	0.15	100,000	15,000	100,000
Aug 19 2019	CGIX	CANCER GENETICS, I ...	Cannon Edmund	Director	Option Exercise	A	0.15	100,000	15,000	100,000
Aug 19 2019	CGIX	CANCER GENETICS, I ...	McLeod Howard	Director	Option Exercise	A	0.15	100,000	15,000	100,000
Feb 01 2019	CGIX	CANCER GENETICS, I ...	ROBERTS JOHN A	Chief Executive Off ...	Buy	P	0.23	185,436	42,650	297,636	112.2 K to 297.6 K (+165.27 %)
Feb 01 2019	CGIX	CANCER GENETICS, I ...	Miles Michael Glenn	Chief Financial Off ...	Buy	P	0.23	150,000	34,500	150,000	0 to 150 K
Feb 01 2019	CGIX	CANCER GENETICS, I ...	Cannon Edmund	Director	Buy	P	0.23	43,479	10,000	61,873	18.4 K to 61.9 K (+236.38 %)
Feb 01 2019	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.23	1,000,000	230,000	4,781,204	3.8 M to 4.8 M (+26.45 %)
Jan 16 2019	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Buy	P	0.23	100,000	22,500	127,500	27.5 K to 127.5 K (+363.64 %)
Jan 16 2019	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.23	1,000,000	225,000	3,781,204	2.8 M to 3.8 M (+35.96 %)
Jan 16 2019	CGIX	CANCER GENETICS, I ...	ROBERTS JOHN A	Chief Executive Off ...	Buy	P	0.23	100,000	22,500	112,200	12.2 K to 112.2 K (+819.67 %)
Jan 16 2019	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Buy	P	0.23	100,000	22,500	127,500	27.5 K to 127.5 K (+363.64 %)
Jan 16 2019	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.23	1,000,000	225,000	3,781,204	2.8 M to 3.8 M (+35.96 %)
Jan 16 2019	CGIX	CANCER GENETICS, I ...	ROBERTS JOHN A	Chief Executive Off ...	Buy	P	0.23	100,000	22,500	112,200	12.2 K to 112.2 K (+819.67 %)
Sep 20 2018	CGIX	CANCER GENETICS, I ...	McCartney Michael Brian	Chief Commercial Of ...	Option Exercise	A	1.03	100,000	103,000	100,000
May 14 2018	CGIX	CANCER GENETICS, I ...	Shaknovich Rita	Chief Medical Offic ...	Option Exercise	A	0.89	50,000	44,500	50,000
May 14 2018	CGIX	CANCER GENETICS, I ...	Brandt Ralf	President, Discover ...	Option Exercise	A	0.89	150,000	133,500	150,000
May 14 2018	CGIX	CANCER GENETICS, I ...	ROBERTS JOHN A	Chief Executive Off ...	Option Exercise	A	0.89	350,000	311,500	350,000
Dec 18 2017	CGIX	CANCER GENETICS, I ...	ROBERTS JOHN A	Chief Operating Off ...	Buy	P	2.00	12,200	24,339	12,200	0 to 12.2 K
Dec 11 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	1.86	150,000	279,000	2,781,204	2.6 M to 2.8 M (+5.70 %)
Oct 02 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	A	2.75	5,000	13,750	5,000
Oct 02 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Grant	A	0.00	2,500	0	2,631,204	2.6 M to 2.6 M (+0.10 %)
Oct 02 2017	CGIX	CANCER GENETICS, I ...	PRENDERGAST FRANKLYN G	Director	Option Exercise	A	2.75	5,000	13,750	5,000
Oct 02 2017	CGIX	CANCER GENETICS, I ...	PRENDERGAST FRANKLYN G	Director	Grant	A	0.00	2,500	0	12,500	10 K to 12.5 K (+25.00 %)
Oct 02 2017	CGIX	CANCER GENETICS, I ...	Welsh Michael J.	Director	Option Exercise	A	2.75	5,000	13,750	5,000
Oct 02 2017	CGIX	CANCER GENETICS, I ...	Welsh Michael J.	Director	Grant	A	0.00	2,500	0	12,540	10 K to 12.5 K (+24.90 %)
Oct 02 2017	CGIX	CANCER GENETICS, I ...	McLeod Howard	Director	Option Exercise	A	2.75	5,000	13,750	5,000
Oct 02 2017	CGIX	CANCER GENETICS, I ...	McLeod Howard	Director	Grant	A	0.00	2,500	0	13,500	11 K to 13.5 K (+22.73 %)
Oct 02 2017	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Option Exercise	A	2.75	5,000	13,750	5,000
Oct 02 2017	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Grant	A	0.00	2,500	0	27,500	25 K to 27.5 K (+10.00 %)
Oct 02 2017	CGIX	CANCER GENETICS, I ...	Chaganti Raju S.K.	Director	Option Exercise	A	2.75	5,000	13,750	5,000
Oct 02 2017	CGIX	CANCER GENETICS, I ...	Chaganti Raju S.K.	Director	Grant	A	0.00	2,500	0	144,071	141.6 K to 144.1 K (+1.77 %)
Oct 02 2017	CGIX	CANCER GENETICS, I ...	Cannon Edmund	Director	Option Exercise	A	2.75	5,000	13,750	5,000
Oct 02 2017	CGIX	CANCER GENETICS, I ...	Cannon Edmund	Director	Grant	A	0.00	2,500	0	18,394	15.9 K to 18.4 K (+15.73 %)
Aug 18 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	3.28	20,000	65,560	2,628,704	2.6 M to 2.6 M (+0.77 %)
Aug 18 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	3.24	66,185	214,108	2,608,704	2.5 M to 2.6 M (+2.60 %)
Jun 12 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	3.75	100,000	374,870	2,542,519	2.4 M to 2.5 M (+4.09 %)
Jun 08 2017	CGIX	CANCER GENETICS, I ...	McLeod Howard	Director	Option Exercise	A	4.15	10,000	41,500	10,000
Jun 08 2017	CGIX	CANCER GENETICS, I ...	McLeod Howard	Director	Grant	A	0.00	2,500	0	11,000	8.5 K to 11 K (+29.41 %)
Jun 08 2017	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Option Exercise	A	4.15	10,000	41,500	10,000
Jun 08 2017	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Grant	A	0.00	2,500	0	25,000	22.5 K to 25 K (+11.11 %)
Jun 08 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	A	4.15	10,000	41,500	10,000
Jun 08 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Grant	A	0.00	2,500	0	2,442,519	2.4 M to 2.4 M (+0.10 %)
Jun 08 2017	CGIX	CANCER GENETICS, I ...	Cannon Edmund	Director	Option Exercise	A	4.15	10,000	41,500	10,000
Jun 08 2017	CGIX	CANCER GENETICS, I ...	Cannon Edmund	Director	Grant	A	0.00	2,500	0	15,894	13.4 K to 15.9 K (+18.67 %)
Jun 08 2017	CGIX	CANCER GENETICS, I ...	Chaganti Raju S.K.	Director	Option Exercise	A	4.15	10,000	41,500	10,000
Jun 08 2017	CGIX	CANCER GENETICS, I ...	Chaganti Raju S.K.	Director	Grant	A	0.00	2,500	0	141,571	139.1 K to 141.6 K (+1.80 %)
Jun 08 2017	CGIX	CANCER GENETICS, I ...	PRENDERGAST FRANKLYN G	Director	Option Exercise	A	4.15	10,000	41,500	10,000
Jun 08 2017	CGIX	CANCER GENETICS, I ...	PRENDERGAST FRANKLYN G	Director	Grant	A	0.00	2,500	0	10,000	7.5 K to 10 K (+33.33 %)
Jun 08 2017	CGIX	CANCER GENETICS, I ...	Welsh Michael J.	Director	Option Exercise	A	4.15	10,000	41,500	10,000
Jun 08 2017	CGIX	CANCER GENETICS, I ...	Welsh Michael J.	Director	Grant	A	0.00	2,500	0	10,040	7.5 K to 10 K (+33.16 %)
May 25 2017	CGIX	CANCER GENETICS, I ...	Gitelman Igor	Chief Accounting Of ...	Option Exercise	M	2.50	937	2,343	14,063
May 25 2017	CGIX	CANCER GENETICS, I ...	Gitelman Igor	Chief Accounting Of ...	Buy	P	3.95	937	3,701	937	0 to 937
May 25 2017	CGIX	CANCER GENETICS, I ...	Gitelman Igor	Chief Accounting Of ...	Sell	S	4.02	937	3,763	0	937 to 0 (-100.00 %)
May 25 2017	CGIX	CANCER GENETICS, I ...	Gitelman Igor	Chief Accounting Of ...	Buy	M	2.50	937	2,343	937	0 to 937
May 17 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	3.80	19,310	73,318	2,440,019	2.4 M to 2.4 M (+0.80 %)
May 16 2017	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Buy	P	3.75	2,500	9,375	22,500	20 K to 22.5 K (+12.50 %)
Feb 24 2017	CGIX	CANCER GENETICS, I ...	SHARMA PANNA	Chief Executive Off ...	Option Exercise	A	2.50	200,000	500,000	200,000
Feb 24 2017	CGIX	CANCER GENETICS, I ...	ROBERTS JOHN A	Chief Operating Off ...	Option Exercise	A	2.50	30,000	75,000	30,000
Feb 24 2017	CGIX	CANCER GENETICS, I ...	Gitelman Igor	Chief Accounting Of ...	Option Exercise	A	2.50	15,000	37,500	15,000
Dec 14 2016	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Buy	P	1.50	2,500	3,750	20,000	17.5 K to 20 K (+14.29 %)
Nov 29 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	1.45	100,000	145,280	2,420,709	2.3 M to 2.4 M (+4.31 %)
Nov 16 2016	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Buy	P	1.55	5,000	7,750	17,500	12.5 K to 17.5 K (+40.00 %)
Nov 16 2016	CGIX	CANCER GENETICS, I ...	Sitar Edward J	Chief Financial Off ...	Sell	S	1.56	3,333	5,193	14,167	17.5 K to 14.2 K (-19.05 %)
Nov 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	1.48	31,100	46,050	2,320,709	2.3 M to 2.3 M (+1.36 %)
Oct 13 2016	CGIX	CANCER GENETICS, I ...	PRENDERGAST FRANKLYN G	Director	Option Exercise	A	1.81	10,000	18,100	10,000
Oct 13 2016	CGIX	CANCER GENETICS, I ...	PRENDERGAST FRANKLYN G	Director	Grant	A	0.00	2,500	0	7,500	5 K to 7.5 K (+50.00 %)
Oct 13 2016	CGIX	CANCER GENETICS, I ...	Cannon Edmund	Director	Option Exercise	A	1.81	10,000	18,100	10,000
Oct 13 2016	CGIX	CANCER GENETICS, I ...	Cannon Edmund	Director	Grant	A	0.00	2,500	0	13,394	10.9 K to 13.4 K (+22.95 %)
Oct 13 2016	CGIX	CANCER GENETICS, I ...	Chaganti Raju S.K.	Director	Option Exercise	A	1.81	10,000	18,100	10,000
Oct 13 2016	CGIX	CANCER GENETICS, I ...	Chaganti Raju S.K.	Director	Grant	A	0.00	2,500	0	139,071	136.6 K to 139.1 K (+1.83 %)
Oct 13 2016	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Option Exercise	A	1.81	10,000	18,100	10,000
Oct 13 2016	CGIX	CANCER GENETICS, I ...	Harris Geoffrey E.	Director	Grant	A	0.00	2,500	0	12,500	10 K to 12.5 K (+25.00 %)
Oct 13 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	A	1.81	10,000	18,100	10,000
Oct 13 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Grant	A	0.00	2,500	0	2,289,609	2.3 M to 2.3 M (+0.11 %)
Oct 13 2016	CGIX	CANCER GENETICS, I ...	McLeod Howard	Director	Option Exercise	A	1.81	10,000	18,100	10,000
Oct 13 2016	CGIX	CANCER GENETICS, I ...	McLeod Howard	Director	Grant	A	0.00	2,500	0	8,500	6 K to 8.5 K (+41.67 %)
Oct 13 2016	CGIX	CANCER GENETICS, I ...	Welsh Michael J.	Director	Option Exercise	A	1.81	10,000	18,100	10,000
Oct 13 2016	CGIX	CANCER GENETICS, I ...	Welsh Michael J.	Director	Grant	A	0.00	2,500	0	7,540	5 K to 7.5 K (+49.60 %)
Aug 17 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.29	45,000	103,203	2,287,109	2.2 M to 2.3 M (+2.01 %)
Aug 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.20	79,722	175,636	2,242,109	2.2 M to 2.2 M (+3.69 %)
Aug 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.10	67,778	142,652	2,162,387	2.1 M to 2.2 M (+3.24 %)
Jul 13 2016	CGIX	CANCER GENETICS, I ...	ROBERTS JOHN A	Chief Operating Off ...	Option Exercise	A	2.04	120,000	244,800	120,000
May 26 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	P	2.25	158,910	357,548	158,910
May 26 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.00	317,820	0	2,099,609	1.8 M to 2.1 M (+17.84 %)
Mar 18 2016	CGIX	CANCER GENETICS, I ...	McLeod Howard	Director	Buy	P	2.71	1,000	2,710	6,000	5 K to 6 K (+20.00 %)
Mar 17 2016	CGIX	CANCER GENETICS, I ...	SHARMA PANNA	Chief Executive Off ...	Buy	P	2.58	500	1,290	152,500	152 K to 152.5 K (+0.33 %)
Mar 17 2016	CGIX	CANCER GENETICS, I ...	SHARMA PANNA	Chief Executive Off ...	Buy	P	2.60	1,000	2,600	152,000	151 K to 152 K (+0.66 %)
Mar 17 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.64	50,000	132,060	1,771,789	1.7 M to 1.8 M (+2.90 %)
Mar 17 2016	CGIX	CANCER GENETICS, I ...	Welsh Michael J.	Director	Buy	P	2.42	40	97	5,040	5 K to 5 K (+0.80 %)
Mar 16 2016	CGIX	CANCER GENETICS, I ...	SHARMA PANNA	Chief Executive Off ...	Buy	P	2.56	1,000	2,560	151,000	150 K to 151 K (+0.67 %)
Mar 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.62	10,579	27,734	1,721,789	1.7 M to 1.7 M (+0.62 %)
Mar 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.52	89,421	225,144	1,711,210	1.6 M to 1.7 M (+5.51 %)
Nov 16 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	P	5.00	100,000	500,000	100,000
Nov 16 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.00	100,000	0	1,621,789	1.5 M to 1.6 M (+6.57 %)
Nov 16 2015	CGIX	CANCER GENETICS, I ...	Sitar Edward J	Chief Financial Off ...	Option Exercise	P	5.00	5,000	25,000	5,000
Nov 16 2015	CGIX	CANCER GENETICS, I ...	Sitar Edward J	Chief Financial Off ...	Buy	P	0.00	5,000	0	17,500	12.5 K to 17.5 K (+40.00 %)

Page: 1 2 next >